Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Relivion

K-Number: K203419 · 2021-02-16

Decision Date2021-02-16
Product CodePCC
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Relivion is a medical device manufactured by Neurolief , Ltd.. It received FDA 510(k) clearance on 2021-02-16 under approval number K203419. The device is classified under product code PCC. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Relivion?

Relivion is a medical device that received FDA 510(k) clearance on 2021-02-16. It is manufactured by Neurolief , Ltd.. The 510(k) number is K203419.

When was Relivion approved by the FDA?

Relivion received FDA 510(k) clearance on 2021-02-16, under approval number K203419.

What company makes Relivion?

Relivion is manufactured by Neurolief , Ltd..

What is the FDA product code for Relivion?

The FDA product code for Relivion is PCC.

Other Devices by Neurolief , Ltd.

Related Devices (Code: PCC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.